Inappropriate prescribing of proton pump inhibitors in primary care
- 1 January 2007
- journal article
- research article
- Published by Oxford University Press (OUP)
- Vol. 83 (975), 66-68
- https://doi.org/10.1136/pgmj.2006.051151
Abstract
Objectives: To determine if an educational intervention initiated in secondary care can influence prescribing of proton pump inhibitors (PPIs) in the community. Methods: A prospective study of PPI use in patients admitted to medical wards in a university hospital. A simple educational intervention was employed to reduce inappropriate prescribing of PPIs in the community. Results: In the pre-intervention analysis 66/271 (24%) patients were receiving treatment with a PPI prescribed in the community. In 36/66 (54%) patients the PPI had been prescribed inappropriately. Six months after the intervention 91/344 (26%) patients were prescribed a PPI in the community. In only 45 of these 91 (49%) patients was there a recommended indication. Conclusion: The intervention used in this study had no effect on the proportion of patients taking a PPI at the time of hospital admission or on the appropriateness of prescribing in the community.Keywords
This publication has 20 references indexed in Scilit:
- Proton pump inhibitor therapy is a risk factor for Clostridium difficile‐associated diarrhoeaAlimentary Pharmacology & Therapeutics, 2006
- Improving surveillance for Barrett's oesophagusBMJ, 2006
- Use of Gastric Acid–Suppressive Agents and the Risk of Community-Acquired Clostridium difficile–Associated DiseaseJAMA, 2005
- Effect of Implementation of a Dyspepsia and Helicobacter pylori Eradication Guideline in Primary CareDigestion, 2005
- Review article: the long‐term use of proton‐pump inhibitorsAlimentary Pharmacology & Therapeutics, 2005
- Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive DrugsJAMA, 2004
- Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseasesRespiratory Medicine, 2003
- Reducing community dyspepsia drug costs: a controlled trialGut, 2001
- Omeprazole as a risk factor for campylobacter gastroenteritis: case-control studyBMJ, 1996
- Long term acid suppressing treatment in general practiceBMJ, 1994